Overexpression of midbrain-specific transcription factor Nurr1 modifies susceptibility of mouse neural stem cells to neurotoxins.
Lee MA, Lee HS, Lee HS, Cho KG, Jin BK, Sohn S, Lee YS, Ichinose H, Kim SU
Overexpressing the Nurr1 protein in mouse neural stem cells alters how these cells respond to specific neurotoxins, increasing vulnerability to one toxin while decreasing it for another. This suggests that Nurr1 levels influence which cell death pathways are activated during neurotoxic stress.
- Nurr1 overexpression increases sensitivity to the neurotoxin 6-OHDA in mouse stem cells.
- Nurr1 overexpression decreases sensitivity to the neurotoxin MPP+ in mouse stem cells.
- The study uses cell lines, not human patients or clinical data.
- Findings relate to Parkinson's disease mechanisms, not NR4A2 syndrome treatment.
Regulation of synaptic plasticity genes during consolidation of fear conditioning.
Ressler KJ, Paschall G, Zhou XL, Davis M
This study identifies changes in gene expression within the amygdala and other brain regions during the consolidation of fear memories. It highlights that Nurr1 levels increase hours after learning, suggesting a role in long-term memory formation rather than immediate response.
- Fear memory consolidation involves broad neural circuits beyond just the amygdala.
- Nurr1 expression increases 2-4 hours after fear conditioning events.
- Gene regulation occurs only when stimuli support actual behavioral learning.
- The study focuses on synaptic plasticity mechanisms in mammalian brains.
Reduced adrenal activation in a rat line selected for high alcohol sensitivity.
Raatesalmi K, Virtanen A, Sarviharju M, Pelto-Huikko And M, Korpi ER
This study finds that rats bred for high alcohol sensitivity show reduced activation of adrenal genes, including Nurr1, in response to alcohol and stress. The research uses animal models to explore biological mechanisms related to alcohol sensitivity rather than investigating NR4A2-related syndromes or potential treatments.
- Rats with high alcohol sensitivity exhibit blunted adrenal gene activation.
- Nurr1 expression is significantly lower in sensitive rats after alcohol exposure.
- The study focuses on animal models of alcohol sensitivity, not human genetics.
- No findings relate to NR4A2 variants or clinical outcomes for affected children.
Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra.
Chu Y, Kompoliti K, Cochran EJ, Mufson EJ, Kordower JH
Nurr1 levels and dopamine-producing neuron markers decline significantly in the human substantia nigra as people age. This reduction parallels the natural loss of dopamine neurons but does not indicate accelerated cell death, suggesting it is a normal part of aging rather than a disease process.
- Nurr1-positive neurons decrease by 23% in middle age and 46% in old age.
- Dopamine neuron markers decline at the same rate as Nurr1 levels.
- Other neuron types remain stable, indicating specific dopaminergic changes.
- Findings reflect normal phenotypic aging, not neurodegeneration.
Exclusion of the Nurr1 gene in autosomal recessive Parkinson's disease.
Rawal N, Periquet M, Dürr A, de Michele G, Bonifati V, Teive HA, Raskin S, Guimaraes J, Agid Y, Brice A, French Parkinson's Disease Genetics Study Group, European Consortium on Genetic Susceptibility in Parkinson's Disease
This study found no evidence that mutations in the Nurr1 gene cause autosomal recessive Parkinson's disease, suggesting that Nurr1 is not a primary genetic cause of this specific form of Parkinson's.
- Nurr1 gene not linked to recessive Parkinson's disease
- No disease-causing mutations found in Nurr1
- Nurr1 unlikely to be a major cause of recessive Parkinson's
Defining requirements for heterodimerization between the retinoid X receptor and the orphan nuclear receptor Nurr1.
Aarnisalo P, Kim CH, Lee JW, Perlmann T
This study identifies the specific structural regions required for Nurr1 to form complexes with RXR, showing that disrupting this partnership does not impair Nurr1's ability to function as a single unit. The findings clarify how Nurr1 interacts with other proteins but do not provide direct evidence for treating NR4A2-related syndromes in humans.
- Nurr1 functions normally as a monomer even when it cannot bind RXR.
- Specific amino acid changes can block heterodimerization without affecting monomeric activity.
- RXR interaction reduces the baseline transcriptional activity of Nurr1.
- The study maps structural requirements for protein-protein interactions in vitro.
- No human clinical data or therapeutic outcomes are reported.
Requirements for heterodimerization between the orphan nuclear receptor Nurr1 and retinoid X receptors.
Sacchetti P, Dwornik H, Formstecher P, Rachez C, Lefebvre P
This study defines the molecular mechanics of how the NR4A2 protein interacts with other receptors to regulate gene expression in dopamine-producing neurons. It establishes that NR4A2 can function independently and details the specific structural requirements for its heterodimerization with retinoid X receptors.
- NR4A2 activates genes without needing RXR partners or its AF2 domain.
- RXR binding to DNA is a strict requirement for NR4A2 heterodimer formation.
- Specific spacing of NR4A2 binding sites controls retinoid-induced transcriptional activity.
Dopaminergic differentiation of the Nurr1-expressing immortalized mesencephalic cell line CSM14.1 in vitro.
Haas SJ, Wree A
This study demonstrates that rat mesencephalic progenitor cells can differentiate into dopaminergic neurons in a laboratory dish. The researchers observed the upregulation of key enzymes associated with mature dopaminergic neurons during this process.
- The study uses immortalized rat embryonic cells, not human cells or patient data.
- It confirms in vitro differentiation into dopaminergic neurons using standard lab markers.
- No genetic link to NR4A2 syndrome or human clinical outcomes is established.
- The work serves as a basic biological model for cell development.
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E
This study maps the cellular signaling pathways that activate NURR1 in pituitary cells, showing it relies on calcium and MAPK mechanisms. It does not investigate NR4A2-related movement disorders or potential treatments for children.
- Research focuses on pituitary corticotrophs, not dopaminergic neurons relevant to NR4A2 syndrome.
- Study uses mouse cell lines (AtT-20), providing no human clinical evidence.
- No connection to motor symptoms, levodopa response, or gene therapy for NR4A2.
- Details molecular pathways like PKA and MAPK in unrelated endocrine tissue.
Nurr1 affects pRL-TK but not phRG-B internal control plasmid in genetic reporter system.
Matuszyk J, Ziolo E, Cebrat M, Kochel I, Strzadala L
This study identifies a technical flaw in common laboratory assays where the NR4A2 protein (Nurr1) artificially increases the signal of a standard control plasmid, potentially leading to incorrect scientific conclusions. It recommends using an alternative control plasmid (phRG-B) to avoid this interference in future experiments. This finding is strictly methodological and does not provide new information about disease mechanisms or treatments for patients.
- NR4A2 protein artificially boosts the signal of the pRL-TK control plasmid in lab assays.
- This interference causes misinterpretation of experimental results regarding gene transcription.
- The phRG-B plasmid serves as a more reliable internal control for these tests.
- NR4A2 does not affect the Fas Ligand promoter-driven transcription in this context.
The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment.
Wansa KD, Harris JM, Muscat GE
This study details the molecular mechanics of how the related protein Nur77 activates gene expression, focusing on its structural domains and interaction with coactivators. It provides no data on NR4A2/Nurr1 function in humans, clinical outcomes, or potential treatments for NR4A2-related syndromes.
- The research focuses exclusively on Nur77 (NR4A1), not the target gene NR4A2.
- It describes basic molecular biology mechanisms of transcription factor activation.
- No human data, patient phenotypes, or clinical trial results are included.
- Findings do not suggest immediate therapeutic avenues for NR4A2 disorders.
Serum response factor: discovery, biochemistry, biological roles and implications for tissue injury healing.
Chai J, Tarnawski AS
This paper discusses serum response factor (SRF), a protein that controls genes involved in cell growth, nerve function, and muscle development. It does not focus on NR4A2 or related disorders and provides no direct insights into NR4A2-related syndrome or potential treatments.
- SRF regulates genes for cell growth, nerves, and muscles
- SRF is activated by various signals like stress and inflammation
- SRF is vital for heart development and function
- No connection to NR4A2 or related neurodevelopmental conditions
- Findings are not relevant to NR4A2-related syndrome
Corticotropin-releasing hormone signaling in synovial tissue vascular endothelium is mediated through the cAMP/CREB pathway.
McEvoy AN, Bresnihan B, Fitzgerald O, Murphy EP
This study investigates how inflammatory signals affect blood vessels in arthritic joints, finding that the NURR1 protein is present in these tissues alongside its activator. The research demonstrates a specific molecular pathway where inflammation triggers NURR1 production in joint endothelial cells via cAMP signaling. This work focuses entirely on peripheral joint inflammation and vascular biology rather than central nervous system development or dopaminergic function.
- NURR1 and its activator CRH are found in synovial lining and blood vessels of arthritic joints.
- Inflammatory signals activate NURR1 gene expression through the cAMP/CREB pathway in endothelial cells.
- The study uses human rheumatoid arthritis tissue samples to map protein locations.
- Findings link peripheral inflammation mechanisms to NURR1 regulation in joint vasculature.
- No connection is established between these findings and NR4A2-related neurodevelopmental syndromes.
Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers.
Bannon MJ, Pruetz B, Manning-Bog AB, Whitty CJ, Michelhaugh SK, Sacchetti P, Granneman JG, Mash DC, Schmidt CJ
Chronic cocaine use significantly reduces the levels of the NURR1 protein and its target, the dopamine transporter, in human brain cells. This finding demonstrates that environmental factors can downregulate NR4A2-dependent pathways in humans, distinct from genetic causes.
- Cocaine abuse lowers NURR1 expression in human dopamine neurons.
- Reduced NURR1 leads to decreased dopamine transporter levels.
- This study confirms NURR1 regulates human DAT gene expression in vivo.
- Findings relate to environmental adaptation, not genetic NR4A2 syndrome.
Activation of nuclear orphan receptor NURR1 transcription by NF-kappa B and cyclic adenosine 5'-monophosphate response element-binding protein in rheumatoid arthritis synovial tissue.
McEvoy AN, Murphy EA, Ponnio T, Conneely OM, Bresnihan B, FitzGerald O, Murphy EP
In rheumatoid arthritis, inflammatory signals boost the NURR1 protein, which may help control joint inflammation. NURR1 is turned on by two key pathways—NF-kappaB and CREB—activated by common inflammatory chemicals like TNF-alpha and PGE2.
- NURR1 levels are high in rheumatoid arthritis joints
- Inflammation boosts NURR1 via NF-kappaB and CREB
- TNF-alpha and PGE2 trigger NURR1 production
- NURR1 may be a central switch for inflammation
- This suggests possible new treatment targets
Early induction of nerve growth factor-induced genes after liver resection-reperfusion injury.
Ohkubo T, Sugawara Y, Sasaki K, Maruyama K, Ohkura N, Makuuchi M
The NGFI-B family of genes, including NR4A2 (Nurr1), is rapidly activated in liver cells after injury from reduced blood flow and restored circulation. This activation is linked to a signaling pathway involving CREB, which may help regulate liver repair.
- NR4A2 (Nurr1) genes turn on within 30 minutes after liver injury
- The CREB protein binds to NR4A2 genes after injury
- This response happens in both rats and humans
- The pathway may help the liver regenerate after damage
Generation of tyrosine hydroxylase-immunoreactive neurons in ventral mesencephalic tissue of Nurr1 deficient mice.
Tornqvist N, Hermanson E, Perlmann T, Stromberg I
This study shows that Nurr1-deficient mouse brain tissue can still produce dopamine-producing neurons when grown in specific laboratory conditions with support from wild-type tissue. However, these neurons fail to form proper nerve fiber bundles and do not develop without additional growth factors or supportive tissue. This suggests that while the gene is not strictly required for neuron creation in a dish, it remains essential for normal structural development.
- Nurr1-deficient mouse tissue produces dopamine neurons when co-cultured with wild-type striatum.
- Neurons lack proper nerve fiber bundles without supportive wild-type tissue environment.
- Growth factors EGF and FGF-8 cannot rescue neuron formation in isolated knockout cultures.
- Results indicate Nurr1 is not required for initial dopamine neuron generation in vitro.
Retinoic acid prevents experimental Cushing syndrome.
Páez-Pereda M, Kovalovsky D, Hopfner U, Theodoropoulou M, Pagotto U, Uhl E, Losa M, Stalla J, Grübler Y, Missale C, Arzt E, Stalla GK
Retinoic acid reduces ACTH and cortisol production while killing tumor cells in mouse models of Cushing syndrome. This effect relies on the absence of the COUP-TFI protein, which is missing in these tumors but present in normal tissue.
- Retinoic acid lowers ACTH and cortisol levels in experimental Cushing syndrome mice.
- The treatment kills ACTH-secreting tumor cells without harming normal cells.
- COUP-TFI protein blocks retinoic acid's effect, explaining its selectivity for tumors.
Silencing mediator of retinoid and thyroid hormone receptors and activating signal cointegrator-2 as transcriptional coregulators of the orphan nuclear receptor Nur77.
Sohn YC, Kwak E, Na Y, Lee JW, Lee SK
This study identifies two proteins that regulate the activity of Nur77 (NR4A2) in laboratory cell cultures. It demonstrates that one protein enhances NR4A2 function while another suppresses it, though the exact mechanism of suppression does not involve standard histone modification pathways.
- SMRT and ASC-2 act as corepressors and coactivators for Nur77 respectively.
- Nur77 interacts directly with SMRT but binds ASC-2 indirectly via an adaptor.
- Histone deacetylase inhibitors do not block SMRT-mediated repression of Nur77.
- SMRT likely competes with an adaptor molecule for binding sites on Nur77.
Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells.
Castro DS, Hermanson E, Joseph B, Wallén A, Aarnisalo P, Heller A, Perlmann T
This study shows that Nurr1 and retinoids can force immature dopamine cells to stop dividing and mature in a laboratory dish. The findings describe basic cellular mechanisms of differentiation but do not involve human patients or animal models.
- Nurr1 induces cell cycle arrest and morphological differentiation in dopamine MN9D cells.
- Retinoids promote differentiation independently of Nurr1 in this cell line model.
- Related receptors NGFI-B and Nor1 also induce growth inhibition and differentiation.
- The mechanism relies on DNA binding without requiring RXR heterodimerization.
A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease.
Carvey PM, Ling ZD, Sortwell CE, Pitzer MR, McGuire SO, Storch A, Collier TJ
Clonally expanded rat mesencephalic progenitor cells differentiate into dopamine neurons when treated with specific cytokines and restore motor function in a Parkinson's disease rat model. This study demonstrates that hematopoietic cytokines can reliably convert these progenitors into functional dopamine neurons suitable for transplantation.
- Rat mesencephalic progenitor cells differentiate into dopamine neurons using interleukin-1, IL-11, LIF, and GDNF.
- A single clonal line achieved 98% conversion to tyrosine hydroxylase-positive neurons.
- Transplanted cells significantly reduced rotational asymmetry in dopamine-depleted rats.
- Differentiated cells maintained stability after cryopreservation and multiple culture passages.
In vitro regulated expression of tyrosine hydroxylase in ventral midbrain neurons from Nurr1-null mouse pups.
Eells JB, Rives JE, Yeung SK, Nikodem VM
This study shows that dopaminergic neuron precursors in mice lacking the Nurr1 gene remain undifferentiated and can be induced to produce tyrosine hydroxylase when treated with specific chemical agents in a lab dish. The research demonstrates that these cells retain some plasticity despite the genetic defect, suggesting potential pathways for cellular rescue. However, this is an in vitro mouse study with no direct clinical application or human data.
- Nurr1-null mouse neurons remain undifferentiated and can express tyrosine hydroxylase in culture.
- Forskolin treatment significantly increases the percentage of tyrosine hydroxylase-positive neurons.
- Combining forskolin, BDNF, and dopamine further enhances tyrosine hydroxylase expression.
- GDNF and BDNF alone do not induce tyrosine hydroxylase in these Nurr1-null cells.
- The study uses mouse pups and cell cultures, providing no human clinical evidence.
Physiological patterns of electrical stimulation can induce neuronal gene expression by activating N-type calcium channels.
Brosenitsch TA, Katz DM
Physiological electrical stimulation patterns activate N-type calcium channels to drive the expression of neuronal genes, including NR4A2 (Nurr1), through distinct signaling pathways than chronic depolarization. This mechanism links specific neural activity patterns directly to gene regulation via PKA and PKC kinases rather than the MAPK pathway.
- Patterned stimulation activates N-type calcium channels to induce NR4A2 expression.
- Chronic depolarization relies on L-type channels, a different mechanism entirely.
- NR4A2 induction by patterned activity requires PKA and PKC kinases.
- The MAPK pathway does not mediate this specific gene expression response.
Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritis.
Murphy EP, McEvoy A, Conneely OM, Bresnihan B, FitzGerald O
This study shows that the protein NURR1 helps drive inflammation in human joints affected by arthritis. It finds that inflammatory signals increase NURR1 levels, which then regulate other molecules involved in the immune response within the joint tissue.
- NURR1 is abundant in inflammatory cells within arthritic joints.
- Inflammatory cytokines increase NURR1 expression in synovial tissue.
- Glucocorticoids suppress the production of NURR1 mRNA.
- NURR1 mediates inflammatory responses in human arthritis models.
Pitx3 activates mouse tyrosine hydroxylase promoter via a high-affinity binding site.
Lebel M, Gauthier Y, Moreau A, Drouin J
This study shows that the transcription factor Pitx3 directly activates the tyrosine hydroxylase gene in mouse neurons, while Nurr1 (NR4A2) has no effect on this specific promoter. The findings highlight distinct regulatory mechanisms for dopamine-related genes in midbrain development. This work does not provide new insights into NR4A2 function or potential treatments for NR4A2-related syndromes.
- Pitx3 activates the tyrosine hydroxylase promoter via a specific binding site in mice.
- Nurr1 (NR4A2) does not influence tyrosine hydroxylase promoter activity in this model.
- The study focuses on mouse neuronal development, not human genetics or therapy.
- Results suggest Pitx3 and Nurr1 regulate dopamine pathways through different mechanisms.
Distribution of the orphan nuclear receptor Nurr1 in medaka (Oryzias latipes): cues to the definition of homologous cell groups in the vertebrate brain.
Kapsimali M, Bourrat F, Vernier P
This study maps where the NR4A2 gene is active in fish brains to understand how brain structures evolved across vertebrates. It confirms that specific brain regions containing NR4A2 in fish correspond to similar regions in mammals, supporting the idea that these neural pathways are evolutionarily conserved. The research provides no direct information on human disease mechanisms or treatments for NR4A2-related syndromes.
- Researchers identified the NR4A2 gene equivalent in medaka fish and mapped its activity in their brains.
- NR4A2 appears in many brain areas, including those linked to nerve function and hormone regulation.
- The study compares fish and mammal brains to identify evolutionarily similar cell groups.
- Results suggest the role of NR4A2 in nervous system development is conserved across vertebrates.
- No human clinical data, patient outcomes, or therapeutic strategies are presented.
Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism.
Sacchetti P, Mitchell TR, Granneman JG, Bannon MJ
This study identifies a new way the NR4A2 protein regulates dopamine transporter production in dopaminergic neurons. It shows that NR4A2 activates this gene through a mechanism that does not require its usual binding sites, suggesting complex control over dopamine signaling.
- NR4A2 increases transcription of the human dopamine transporter gene.
- This activation occurs independently of heterodimerization with RXR receptors.
- The mechanism bypasses standard NBRE-like binding sites on the DNA.
- Findings come from cell line experiments, not human or animal models.
Parathyroid hormone induces expression of the nuclear orphan receptor Nurr1 in bone cells.
Tetradis S, Bezouglaia O, Tsingotjidou A
Parathyroid hormone triggers the production of Nurr1 in mouse bone cells through a specific signaling pathway. This finding describes a molecular mechanism in osteoblasts and does not provide information about human neurodevelopment or clinical outcomes for NR4A2-related syndromes.
- The study uses primary mouse osteoblasts, not human neural tissue or patient samples.
- It investigates bone cell biology rather than dopaminergic neuron function or development.
- No clinical data, patient phenotypes, or treatment effects in humans are reported.
- Nurr1 induction occurs via the cAMP/PKA pathway in response to parathyroid hormone.
Expression of Nuclear Orphan Receptors Ngfi-B/Tr3, Nurr1 And Nor-1 after Global Brain Ischemia in Rat.
Schmidt-Kastner R, Zetterstr M R, Hakim AM
This study examines how three specific nuclear receptors, including Nurr1 (NR4A2), change their expression levels in rat brains following global ischemia. It provides no information on human NR4A2-related syndromes or potential treatments for affected children.
- The research focuses on rat models of brain ischemia, not human genetic conditions.
- It measures Nurr1 expression changes after oxygen deprivation in animal tissue.
- No clinical data, patient phenotypes, or therapeutic interventions are reported.
- The findings do not translate to current management of NR4A2-related syndromes.
Stress induces zinc finger immediate early genes in the rat adrenal gland.
Honkaniemi J, Zhang JS, Longo FM, Sharp FR
Stress rapidly activates the Nurr1 gene in rat adrenal glands alongside other immediate-early genes, suggesting it plays a role in hormone secretion during stress responses. This study provides no information on human NR4A2 variants, neurodevelopmental phenotypes, or potential treatments for children with NR4A2-related syndromes.
- Nurr1 activates quickly in rat adrenal glands after stress exposure.
- The study focuses on hormone secretion mechanisms in rats.
- No human data, clinical cohorts, or treatment implications are presented.
- Findings do not address NR4A2-related neurodevelopmental disorders.
Hippocampal expression of the orphan nuclear receptor gene hzf-3/nurr1 during spatial discrimination learning.
Peña de Ortiz S, Maldonado-Vlaar CS, Carrasquillo Y
This study shows that the NR4A2 gene becomes more active in the rat hippocampus when animals learn a spatial memory task. The findings link NR4A2 expression to long-term memory formation in rodents but do not address human disease mechanisms or treatment options.
- NR4A2 mRNA levels rise in rat hippocampus during spatial learning.
- Increased expression occurs specifically in CA1 and CA3 brain regions.
- The study uses a maze-based food search task in adult rats.
- No human data, clinical trials, or therapeutic implications are presented.
Identification of a potential nurr1 response element that activates the tyrosine hydroxylase gene promoter in cultured cells.
Iwawaki T, Kohno K, Kobayashi K
This study identifies a specific DNA sequence in the tyrosine hydroxylase gene that allows Nurr1 to activate dopamine production in cultured cells. It confirms the molecular mechanism by which NR4A2 regulates the enzyme necessary for dopamine synthesis. This work provides foundational biological context but offers no direct clinical guidance or treatment options for patients.
- Nurr1 directly activates the tyrosine hydroxylase gene promoter in cultured cells.
- Researchers identified a specific Nurr1 response element within the TH gene promoter.
- This mechanism explains how NR4A2 controls dopamine-producing neuron development.
- The study uses cell lines, not human patients or animal models.
- Findings describe basic molecular biology without clinical application.
The aging process: where are the drug opportunities?
Smith RG
This review identifies Nurr1 as a potential drug target for Parkinson's disease and highlights other emerging therapeutic avenues in aging research. It does not provide specific information, genetic insights, or treatment protocols relevant to NR4A2-related syndromes.
- Nurr1 is identified as a potential drug target for Parkinson's disease treatment.
- Growth hormone secretagogue receptor agonists show rejuvenating properties in aging research.
- The paper reviews general aging mechanisms without focusing on NR4A2 or related conditions.
- No human clinical data or specific guidance for NR4A2 families is included.
A response element for the homeodomain transcription factor Ptx3 in the tyrosine hydroxylase gene promoter.
Cazorla P, Smidt MP, O'Malley KL, Burbach JP
The transcription factor Ptx3 binds to the promoter of the tyrosine hydroxylase gene and enhances its activity in dopaminergic neurons, particularly when working together with Nurr1. This interaction suggests that Ptx3 helps regulate the production of dopamine-related enzymes in specific brain regions.
- Ptx3 binds to a specific site on the tyrosine hydroxylase gene promoter.
- Ptx3 enhances TH gene activity eight- to twelve-fold in neuroblastoma cells.
- Nurr1 significantly boosts the ability of Ptx3 to activate the TH promoter.
- Ptx3 represses TH activity in non-neuronal kidney cells, showing cell-type specificity.
The lack of Nurr1 does not effect cholecystokinin mRNA expression in the ventral midbrain in newborn mouse.
Baffi J, Witta J, Mezey E, Nikodem VM, Palkovits M
This study found that removing the Nurr1 gene in newborn mice does not change the levels of cholecystokinin mRNA in the ventral midbrain, suggesting that Nurr1 is not required for cholecystokinin expression in this brain region during early development.
- Nurr1 is not needed for cholecystokinin mRNA in newborn mouse midbrain
- No change in cholecystokinin levels when Nurr1 is absent
- Findings suggest Nurr1's role may be limited to other genes or brain areas
Genetic and epigenetic control of midbrain dopaminergic neuron development.
Perrone-Capano C, Di Porzio U
This review outlines the molecular steps required for midbrain dopaminergic neurons to develop and function, highlighting the essential roles of Nurr1 (NR4A2) and Ptx3 transcription factors. It describes how these genes interact with signaling molecules like Sonic hedgehog and FGF8 to specify neuron identity and coordinate synaptic connections.
- Nurr1 and Ptx3 are required for the final determination of dopaminergic neurons.
- Sonic hedgehog and FGF8 commit progenitor cells to become dopaminergic neurons.
- Target cell interactions modulate dopamine synthesis and uptake functions.
- Grafted neurons mature similarly to naturally developing fetal neurons.
Epigenetic cues in midbrain dopaminergic neuron development.
Perrone-Capano C, Da Pozzo P, di Porzio U
This review outlines the normal developmental steps required for midbrain dopaminergic neurons to form and function, highlighting the essential role of the transcription factor Nurr1 (NR4A2). It describes how external signals and target tissue interactions guide these neurons from initial commitment to mature neurotransmitter activity. The paper provides a baseline understanding of healthy neuron development rather than specific insights into NR4A2-related syndromes.
- Nurr1 is required for the final determination of midbrain dopaminergic neurons.
- Sonic Hedgehog and FGF8 act as initial extracellular inducers for these cells.
- Target tissue interaction modulates dopamine function in developing neurons.
- Dopamine synthesis occurs shortly after Nurr1 expression during development.
Activity of the Nurr1 carboxyl-terminal domain depends on cell type and integrity of the activation function 2.
Castro DS, Arvidsson M, Bondesson Bolin M, Perlmann T
This study shows that the Nurr1 protein can activate genes on its own without needing a known ligand, but this ability depends heavily on the specific cell type and other cellular factors. It identifies unique features of the AF2 region that drive this activity and notes that standard coactivators do not stimulate Nurr1 as they do other receptors. The findings suggest that an unknown ligand might eventually modulate Nurr1's function in the brain, but no direct treatment pathway is established.
- Nurr1 activates genes constitutively without a known ligand in certain cell types.
- The AF2 region drives this activation independently of external signals.
- Standard coactivators like SRC-1 do not stimulate Nurr1 activity.
- Cell type and DNA binding mode determine Nurr1's transcriptional capacity.
- Results hint at an unidentified ligand but offer no immediate clinical application.
A selective group of dopaminergic neurons express Nurr1 in the adult mouse brain.
Bäckman C, Perlmann T, Wallén A, Hoffer BJ, Morales M
This study maps where the Nurr1 protein is found in adult mouse brains, showing it is present in most midbrain and olfactory dopaminergic neurons but absent in others. It confirms that Nurr1 is not required for all dopamine-producing cells in the brain.
- Nurr1 is present in 91-96% of midbrain dopaminergic neurons in adult mice.
- Most olfactory bulb dopaminergic neurons also express Nurr1.
- Hypothalamic and arcuate nucleus dopamine neurons do not express Nurr1.
- Nurr1 is absent from brainstem noradrenergic neurons.
- The study uses mouse tissue, not human patients or clinical data.
Characterization of the 5'-flanking region of the human dopamine transporter gene.
Sacchetti P, Brownschidle LA, Granneman JG, Bannon MJ
This study maps the regulatory DNA region controlling the dopamine transporter gene and confirms that the protein Nurr1 (encoded by NR4A2) increases its activity in laboratory cell cultures. It provides mechanistic insight into how NR4A2 influences dopamine signaling but does not test treatments or analyze patient outcomes. The findings are basic molecular biology with no direct clinical application for your child at this time.
- Researchers mapped the DNA region controlling the human dopamine transporter gene.
- Nurr1 protein increases the activity of the dopamine transporter in cell studies.
- The study identifies specific DNA binding sites where Nurr1 acts on the gene.
- No animal models, patient data, or treatment trials are included in this work.